Search Results - Laura Locati
- Showing 1 - 2 results of 2
-
1
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II st... by Sophie Leboulleux, Ellen Kapiteijn, Saskia Litière, Patrick Schöffski, Yann Godbert, Patrice Rodien, Barbara Jarzab, Domenico Salvatore, Sylvie Zanetta, Jaume Capdevila, Lars Bastholt, Christelle De La Fouchardiere, Yassine Lalami, Stéphane Bardet, Frank Cornélis, Marek Dedecjus, Thera Links, Ward Sents, Martin Schlumberger, D. Laura Locati, Katie Newbold
Published in Frontiers in Endocrinology (2024-06-01)Get full text
Article -
2
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM) by Oriana Ciani, Carla Ida Ripamonti, Fabio Efficace, Giuseppe Viscardi, Francesco De Lorenzo, Massimo Di Maio, Lara Gitto, Elisabetta Iannelli, Francesco Perrone, Ethan Basch, Alessandra Raimondi, Antonella Brunello, Carmine Pinto, Alberto Puccini, Silvana Quaglini, Evaristo Maiello, Martina Pagliuca, Saverio Cinieri, Gianmauro Numico, Paolo Bossi, Patrizia Popoli, Tiziana Latiano, Laura Marandino, Francesco Longo, Alberto Servetto, Angela Piattelli, Giordano Domenico Beretta, Davide Petruzzelli, Marco Zibellini, Laura Locati, Gualberto Gussoni, Gianluca Mignone, Pricivel M Carrera
Published in BMJ Oncology (2025-06-01)Get full text
Article
